Following WCLC 2026, Katherine Kuhns details how perioperative immunotherapy, AI patient tools, and wearables are transforming thoracic surgical nursing care.
Feature|Articles|July 24, 2026
Nurses Lead the Way in the New Era of Chronic Lung Cancer Care
Author(s)Alex Biese
Fact checked by: Tracy Ann Politowicz
Oncology nurses discuss managing lung cancer as a chronic disease, addressing long-term symptoms, financial toxicity, and psychosocial care.
Advertisement
Advertisement
When Beth Sandy, CRNP, started her career at the Abramson Cancer Center at the University of Pennsylvania 23 years ago, the clinical landscape for lung cancer was a stark contrast to the modern era. "I’ve seen a lot in lung cancer from the start when we only had just a couple of drugs," Sandy recalls.
Related to this article
Jyoti Malhotra, MD, MPH, joins The Moonlight Shift to discuss first-in-human phase 1 lung cancer trials, healthcare access, and her work at Yale Cancer Center.
Adding atezolizumab to adjuvant FOLFOX halved the risk of recurrence or death in ATOMIC, with more grade 3 to 4 adverse events.
Real-time check-ins from patients with MBC showed quality of life dipped when depression, anxiety, or fatigue rose above usual levels.
FDA approves tucatinib maintenance with trastuzumab and pertuzumab for HER2+ breast cancer based on HER2CLIMB-05.
In observation of National PA Week, Moffitt PA Mark Honor discusses the expansion of APPs and key collaboration strategies for oncology nurses.
Beth Faiman details the new IMS/IMWG consensus definition of cure for multiple myeloma, requiring 5 years of treatment-free remission.
Advertisement
Advertisement